Evidence Type | Evidence Description | Score |
---|---|---|
Mined from Literature | Inference of an interaction from in silico textual analysis of a published paper by a natural language processing (NLP) algorithm. | 0 |
Binding site/Promoter Interaction: | ||
Transient transfection | Perturbation of expression of a reporter under control of the downstream gene promoter on disruption of upstream gene expression | 10 |
Stable transgenic line | Perturbation of expression of a reporter under control of the downstream gene promoter on disruption of upstream gene expression | 10 |
Protein synthesis inhibition | Demonstration of a direct interaction by inhibition of intermediate protein production using cyclohexamide or other inhibitors. | 50 |
In silico prediction | Prediction of a binding site for the upstream gene product in the downstream gene promoter using in silico methods. | 2 |
Elecrophoretic Mobility Shift Assay (EMSA) | EMSA showing direct binding between the upstream gene product and a fragment of the downstream gene promoter in vitro. | 25 |
DNase Footprinting | Protection of a putative binding site in radiolabelled DNA containing the downstream gene promoter by the upstream gene product. | 25 |
ChIP-on-chip | Chromatin Immunoprecipitation using antibody for the upstream gene, and analysis of the binding site locations on a microarray. | 25 |
Expression Evidence: | ||
Stable transgenic reporter | Transgenic organism carrying a reporter gene under the control of the promoter of the gene of interest. | 25 |
Transient transgenic reporter | Transient transfection of a construct carrying a reporter gene under the control of the promoter of the gene of interest. | 25 |
SAGE | Detection of a sequence tag from an mRNA in a Serial Analysis of Gene Expression experiment. | 10 |
RT-PCR | Measurement of mRNA by Reverse-Transcription Polymerase Chain Reaction. | 10 |
Primer extension | Extension of a gene-specific primer using an mRNA template. | 10 |
Nuclease protection | Measurement of mRNA by hybridization with an antisense probe followed by ribonuclease digestion of unbound RNA. | 10 |
Northern Blot | Measurement of mRNA by northern blot. | 10 |
In situ hybridisation | Measurement of mRNA by in-situ hybridization. | 25 |
cDNA Library | Isolation of a gene from a cDNA library. | 10 |
Array | Measurement of mRNA on an expression DNA microarray. | 10 |
Western blot | Measurement of protein by western blot. | 10 |
Mass Spectrometry | Detection of protein from cell or tissue extract using mass spectrometry. | 10 |
Immunohistochemistry/immunocytochemistry | Measurement of protein by antibody staining in tissue slices or cultured cells. | 25 |
Perturbation Evidence: | ||
Mutation of binding site | Site-directed mutagenesis of a known binding site of the upstream gene in the downstream gene's promoter leads to a decrease in activity of a reporter gene | 25 |
In silico inference | Inference of an interaction from mathematical modelling of experimental data such as microarray time course. | 2 |
Transient transgenic | Transient transfection of a DNA construct containing the upstream gene, controlled by a constitutive or inducible promoter. | 10 |
Stable transgenic | Stable transgenic cell or organism line containing the upstream gene controlled by a constitutive or inducible promoter. | 10 |
RNA-based overexpression | Introduction of synthetic or purified mRNA of upstream gene into target cells or tissues. | 10 |
Protein-based overexpression | Introduction of synthetic or purified protein product of upstream gene to target cells or tissues. | 10 |
Transgenic knock-out | Stable transgenic cell or organism line with the upstream gene knocked-out either functionally or by expression. | 25 |
RNAi | RNA interference-based knock-down or silencing of the upstream gene. | 25 |
Morpholino | Morpholino-based inhibition of translation of the upstream gene mRNA. | 25 |
Molecular Inhibitor | Use of an inhibitor molecule to reduce or eliminate the function of the upstream gene product. | 10 |
Dominant-negative protein expression | Insertion of a dominant-negative version of an upstream regulator into a system reduces or eliminates expression of the target gene. | 10 |